Genetic Variations in IL-1β, TNF-α, and TGF-β Associated with the Severity of Chronic Cervical Spondylitis in Patients

Cells. 2023 Jun 9;12(12):1594. doi: 10.3390/cells12121594.

Abstract

Chronic cervical spondylitis (CCS), a degenerative disorder of the spine, is known for causing disability among old and young people. Single-nucleotide polymorphisms (SNPs) in various cytokine genes have demonstrated an impactful association with several inflammatory disorders. In the present study, we have investigated the SNPs and allelic distribution of the three most prevalent cytokines genes, IL-1β (-511C/T), TNF-α (-308G/A), and TGF-β (-509C/T), along with serum levels of these cytokines in 252 subjects. SNPs were analyzed using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), and digested fragments were separated and visualized using agarose gel electrophoresis and Native Polyacrylamide gel electrophoresis (PAGE). The serum cytokine levels were analyzed with a flow cytometer using a customized multiplex bead-based assay. It was observed that these SNPs did not reflect the susceptibility to CCS but were associated with susceptibility to CCS. We found a significant association between the C/C and G/G genotypes and the C and G alleles of IL-1β and TNF-α, respectively, suggesting a lower risk of CCS. The frequency distribution of risk alleles (-511T) and (-308A) were simultaneously higher in CCS compared to the control, reflecting the susceptibility to CCS. TGF-β showed a significant association with disease susceptibility, along with a significant correlation between age and the chronicity of CCS. The serum cytokine levels were significantly different in CCS and controls.

Keywords: PCR-RFLP; anti-inflammatory; chronic cervical spondylitis; polymorphisms; pro-inflammatory.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Cytokines / genetics
  • Genetic Predisposition to Disease
  • Humans
  • Polymorphism, Single Nucleotide / genetics
  • Spondylitis*
  • Transforming Growth Factor beta / genetics
  • Tumor Necrosis Factor-alpha* / genetics

Substances

  • Cytokines
  • Transforming Growth Factor beta
  • Tumor Necrosis Factor-alpha
  • TNF protein, human
  • IL1B protein, human

Grants and funding

This work is supported by intramural funds from All India Institute Medical Sciences, Rishikesh, provided to R.A. (AIIMS/102/IM/2015) and A.A.M. (IM/RC150/2018/13).